ClinicalTrials.Veeva

Menu

Comparison of Two Lidocaine Administration Techniques

The University of Chicago logo

The University of Chicago

Status and phase

Completed
Phase 4

Conditions

Pain

Treatments

Drug: lidocaine

Study type

Interventional

Funder types

Other

Identifiers

NCT01330134
10-621A

Details and patient eligibility

About

The objective of our study is to determine if technique of lidocaine administration can decrease pain perception.

Hypothesis: There will be a significant difference in pain perception between patients who are given lidocaine on the skin surface prior to subcutaneous injection and patients who are given only subcutaneous injection by standard approach.

Full description

This is a single center prospective, randomized, blinded study assessing pain perception following 2 different lidocaine administration techniques in subjects who have planned medical procedures requiring local injection of lidocaine. Subjects will be approached and consented to participate in the study. They will be interviewed after the scheduled medical procedure to assess their pain using validated pain scores. An investigator who is not present for the procedure and blinded to the randomization will gather data regarding perceptions of pain from the entire procedure.

Enrollment

481 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients refered to the University of Chicago Medical Centers Procedure Service for a planned medical procedure requiring local injection of lidocaine.

Exclusion criteria

  • Patient who lack decisional capacity to consent
  • Patients who lack the ability to answer questions in english using pain scales

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

481 participants in 2 patient groups

lidocaine onto skin prior to lidocaine subcutaneous injection
Experimental group
Description:
1-2ml of 1% lidocaine dripped onto the surface of the skin immediately prior to subcutaneous injection of 1% lidocaine.
Treatment:
Drug: lidocaine
Drug: lidocaine
lidocaine subcutaneous injection alone
Active Comparator group
Description:
1% lidocaine subcutaneous injection alone by standard approach
Treatment:
Drug: lidocaine
Drug: lidocaine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems